Agonists Research

7 comprehensive market analysis studies and research reports on the Agonists sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 58 companies, enriched with industry statistics, insights, and a lot more.

Agonists Industry Mordor Intelligence
Dots and Lines - Pattern
7 Healthcare Reports
Categoriesdown
Filters and Sort
Middle East And Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market Major Players
Countries Covered: Saudi Arabia, Egypt, Iran, South Africa, Oman, Middle East and Africa
Major Players:AstraZeneca, Sanofi, Eli Lilly and Company, Novo Nordisk, Pfizer
Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market Major Players
Countries Covered: Brazil, Mexico, Argentina, Latin America
Major Players:AstraZeneca, Novo Nordisk, Eli Lilly and Company, Sanofi, Hypera S.A.
Meperidine Drugs Market Major Players
Meperidine Drugs Market
CAGR: 3.9%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Mallinckrodt Pharmaceuticals, Pfizer, Sandoz (Novartis AG), Epic Pharma LLC, Sanofi
Glucagon-like Peptide-1 Agonists Market Major Players
Glucagon-like Peptide-1 Agonists Market
CAGR: 13.26%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk, Pfizer
North America Glucagon-like Peptide-1 Agonists Market Major Players
North America Glucagon-like Peptide-1 Agonists Market
CAGR: 13.14%
Study Period: 2020 - 2031
Countries Covered: United States, Canada, Mexico, North America
Major Players:AstraZeneca, Sanofi, Eli Lilly and Company, Pfizer, Novo Nordisk
Europe Glucagon-Like Peptide-1 Agonists Market Major Players
Europe Glucagon-Like Peptide-1 Agonists Market
CAGR: 5.84%
Study Period: 2020 - 2031
Countries Covered: Germany, Spain, Italy, France, United Kingdom, Russia, Europe
Major Players:Novo Nordisk, AstraZeneca, Eli Lilly and Company, Sanofi, Pfizer
Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market Major Players
Countries Covered: Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Philippines, Vietnam, Asia
Major Players:AstraZeneca, Eli Lilly and Company, Novo Nordisk, Sanofi, Biocon
Yay! You have seen it all
Dots and Lines - Pattern
CONTACT US

When decisions matter, industry leaders turn to our analysts. Let’s talk.

🌐Country code
down